JP2007520521A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007520521A5 JP2007520521A5 JP2006551813A JP2006551813A JP2007520521A5 JP 2007520521 A5 JP2007520521 A5 JP 2007520521A5 JP 2006551813 A JP2006551813 A JP 2006551813A JP 2006551813 A JP2006551813 A JP 2006551813A JP 2007520521 A5 JP2007520521 A5 JP 2007520521A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- dispersible pharmaceutical
- spontaneously dispersible
- nanoparticles
- diluted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0402679.5A GB0402679D0 (en) | 2004-02-06 | 2004-02-06 | Organic compounds |
| PCT/EP2005/001166 WO2005074891A1 (en) | 2004-02-06 | 2005-02-04 | Microemulsion formulations comprising particular substance p antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007520521A JP2007520521A (ja) | 2007-07-26 |
| JP2007520521A5 true JP2007520521A5 (https=) | 2008-03-21 |
Family
ID=31985813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006551813A Pending JP2007520521A (ja) | 2004-02-06 | 2005-02-04 | 特定のサブスタンスｐアンタゴニストを含んでなるマイクロエマルジョン製剤 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20080254113A1 (https=) |
| EP (1) | EP1715848B1 (https=) |
| JP (1) | JP2007520521A (https=) |
| CN (1) | CN1929817B (https=) |
| AT (1) | ATE475409T1 (https=) |
| AU (1) | AU2005210134B2 (https=) |
| BR (1) | BRPI0507492A (https=) |
| CA (1) | CA2553658A1 (https=) |
| DE (1) | DE602005022558D1 (https=) |
| ES (1) | ES2349647T3 (https=) |
| GB (1) | GB0402679D0 (https=) |
| PL (1) | PL1715848T3 (https=) |
| PT (1) | PT1715848E (https=) |
| RU (1) | RU2397759C2 (https=) |
| WO (1) | WO2005074891A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1938804A1 (en) * | 2006-12-22 | 2008-07-02 | Novartis AG | Pharmaceutical formulation comprising neurokinin antagonist |
| RU2481822C1 (ru) * | 2012-02-21 | 2013-05-20 | Автономная некоммерческая организация "Институт медико-биологических исследований и технологий" (АНО "ИМБИИТ") | Микроэмульсионные композиции для создания трансдермальных и трансмукозальных форм фармацевтических средств и косметических препаратов и способ их получения |
| AU2014204739B2 (en) * | 2013-01-14 | 2016-08-11 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| EP3086777A1 (en) * | 2013-12-23 | 2016-11-02 | Johnson & Johnson Consumer Inc. | Racecadotril compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY132550A (en) * | 1996-08-22 | 2007-10-31 | Novartis Ag | Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists |
| NZ502567A (en) * | 1997-07-29 | 2002-03-28 | Upjohn Co | Self-emulsifying formulation for lipophilic compounds containing a pyranone and a mixture of monoglycerides and diglycerides |
| EP1107744B1 (en) * | 1998-08-25 | 2003-04-23 | Novartis AG | Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia |
| SE0000774D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
| MY120392A (en) * | 2000-06-08 | 2005-10-31 | Hovid Berhad | A novel drug delivery system : formulation for fat-soluble drugs |
-
2004
- 2004-02-06 GB GBGB0402679.5A patent/GB0402679D0/en not_active Ceased
-
2005
- 2005-02-04 PT PT05707213T patent/PT1715848E/pt unknown
- 2005-02-04 AT AT05707213T patent/ATE475409T1/de active
- 2005-02-04 AU AU2005210134A patent/AU2005210134B2/en not_active Ceased
- 2005-02-04 PL PL05707213T patent/PL1715848T3/pl unknown
- 2005-02-04 RU RU2006131788/15A patent/RU2397759C2/ru not_active IP Right Cessation
- 2005-02-04 BR BRPI0507492-4A patent/BRPI0507492A/pt not_active IP Right Cessation
- 2005-02-04 US US10/597,313 patent/US20080254113A1/en not_active Abandoned
- 2005-02-04 CA CA002553658A patent/CA2553658A1/en not_active Abandoned
- 2005-02-04 EP EP05707213A patent/EP1715848B1/en not_active Expired - Lifetime
- 2005-02-04 CN CN2005800081031A patent/CN1929817B/zh not_active Expired - Fee Related
- 2005-02-04 DE DE602005022558T patent/DE602005022558D1/de not_active Expired - Lifetime
- 2005-02-04 WO PCT/EP2005/001166 patent/WO2005074891A1/en not_active Ceased
- 2005-02-04 ES ES05707213T patent/ES2349647T3/es not_active Expired - Lifetime
- 2005-02-04 JP JP2006551813A patent/JP2007520521A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005507881A5 (https=) | ||
| BRPI0512829A (pt) | preparação de composições farmacêuticas contendo nanopartìculas | |
| WO2007116954A3 (en) | Inorganic nanoparticle comprising an active substance immobilized on the surface and a polymer | |
| WO2009008923A3 (en) | Methods of making nano-scale structures having controlled size, nanowire structures and methods of making the nanowire structures | |
| JP2011500885A5 (https=) | ||
| CN106563472B (zh) | 金-氯氧铋纳米复合材料及其制备方法 | |
| WO2010041146A3 (en) | Nanocomposite thermoelectric conversion material, thermoelectric conversion element including the same, and method of producing nanocomposite thermoelectric conversion material | |
| WO2006093799A3 (en) | Metal phosphate sols, metal nanoparticles, metal-chalcogenide nanoparticles, and nanocomposites made therefrom | |
| WO2007142888A3 (en) | Concentrated fluoropolymer dispersions stabilized with anionic polyelectrolyte dispersing agents | |
| WO2008074804A3 (en) | Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application | |
| JP2005509596A5 (https=) | ||
| EP1657289A3 (en) | Semiconductor nanoparticle having high luminescence properties | |
| WO2009023304A3 (en) | High density nanotube devices | |
| WO2010102923A3 (en) | Riluzole aqueous suspensions | |
| JP2013047264A5 (https=) | ||
| WO2008005934A3 (en) | Media sheet | |
| Hikida et al. | Formation of spherical D2-brane from multiple D0-branes | |
| JP2007520521A5 (https=) | ||
| JP2008264777A5 (https=) | ||
| WO2008073731A3 (en) | Microemulsion dosage forms of valsartan and methods of making the same | |
| JP2009504909A5 (https=) | ||
| JP2006519093A5 (https=) | ||
| JP2009522138A5 (https=) | ||
| JP2005515064A5 (https=) | ||
| WO2006123354A3 (en) | Oral pharmaceutical composition |